Anastrazole is an aromatase inhibitor for use in the treatment of hormone receptor-positive breast cancer.
EML status history
First added in 2015 (TRS 994) for Malignant neoplasms of breast
Added in 2015 (TRS 994) for Other specified malignant neoplasms of breast
Hormones and antihormones
- Oral > Solid: 1 mg tablet